Report Overview:
The Global Continuous Glucose Monitoring Devices Market achieved a valuation of $5.53 Billion in 2022 and is anticipated to exceed $12.39 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 10.6% during the forecast period from 2024 to 2032.
Key Market Players:
Medtronic (US), Dexcom Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek